IL113837A - [(3,4-difluorophenoxy) methyl] oxirane and its preparation - Google Patents

[(3,4-difluorophenoxy) methyl] oxirane and its preparation

Info

Publication number
IL113837A
IL113837A IL11383792A IL11383792A IL113837A IL 113837 A IL113837 A IL 113837A IL 11383792 A IL11383792 A IL 11383792A IL 11383792 A IL11383792 A IL 11383792A IL 113837 A IL113837 A IL 113837A
Authority
IL
Israel
Prior art keywords
methyl
compound
difluorophenoxy
formula
filtered
Prior art date
Application number
IL11383792A
Other languages
English (en)
Inventor
Raymond Antoine Stokbroekx
Gilbert Arthur Jules Grauwels
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of IL113837A publication Critical patent/IL113837A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Epoxy Compounds (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Paper (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL11383792A 1991-02-25 1992-02-14 [(3,4-difluorophenoxy) methyl] oxirane and its preparation IL113837A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65964591A 1991-02-25 1991-02-25
IL10095292A IL100952A (en) 1991-02-25 1992-02-14 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol its preparation and pharmaceutical compositions containing it

Publications (1)

Publication Number Publication Date
IL113837A true IL113837A (en) 1996-05-14

Family

ID=24646210

Family Applications (3)

Application Number Title Priority Date Filing Date
IL11383792A IL113837A (en) 1991-02-25 1992-02-14 [(3,4-difluorophenoxy) methyl] oxirane and its preparation
IL10095292A IL100952A (en) 1991-02-25 1992-02-14 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol its preparation and pharmaceutical compositions containing it
IL11383795A IL113837A0 (en) 1991-02-25 1995-05-24 [(3,4-difluorophenoxy)methyl] oxirane and its preparation

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL10095292A IL100952A (en) 1991-02-25 1992-02-14 4-[(2-benzothiazolyl)methylamino]-alpha-[(3,4-difluorophenoxy)methyl]-1-piperidineethanol its preparation and pharmaceutical compositions containing it
IL11383795A IL113837A0 (en) 1991-02-25 1995-05-24 [(3,4-difluorophenoxy)methyl] oxirane and its preparation

Country Status (36)

Country Link
US (2) US5434168A (Direct)
EP (2) EP0573473B1 (Direct)
JP (1) JP2825652B2 (Direct)
KR (1) KR0165901B1 (Direct)
CN (3) CN1033454C (Direct)
AT (1) ATE131478T1 (Direct)
AU (1) AU649788B2 (Direct)
BG (1) BG62332B1 (Direct)
CA (1) CA2104000A1 (Direct)
CY (1) CY1924A (Direct)
CZ (1) CZ284705B6 (Direct)
DE (1) DE69206787T2 (Direct)
DK (1) DK0573473T3 (Direct)
DZ (1) DZ1560A1 (Direct)
EE (1) EE02983B1 (Direct)
ES (1) ES2083737T3 (Direct)
FI (1) FI933719A7 (Direct)
GR (1) GR3018692T3 (Direct)
HK (1) HK172296A (Direct)
HU (2) HUT67695A (Direct)
IE (1) IE69567B1 (Direct)
IL (3) IL113837A (Direct)
LV (1) LV11689B (Direct)
MA (1) MA22447A1 (Direct)
MX (1) MX9200777A (Direct)
NO (1) NO300591B1 (Direct)
NZ (2) NZ241592A (Direct)
PL (1) PL168791B1 (Direct)
RO (1) RO112959B1 (Direct)
RU (2) RU2106348C1 (Direct)
SK (1) SK278705B6 (Direct)
TN (1) TNSN92017A1 (Direct)
TW (1) TW218016B (Direct)
WO (1) WO1992014731A1 (Direct)
ZA (1) ZA921341B (Direct)
ZW (1) ZW1992A1 (Direct)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
TW282469B (Direct) * 1993-06-11 1996-08-01 Janssen Pharmaceutica Nv
FI971534A0 (fi) * 1994-10-14 1997-04-11 Janssen Pharmaceutica Nv Oraalisia sabelutsolisuspensioita
AU693969B2 (en) * 1994-11-24 1998-07-09 Janssen Pharmaceutica N.V. Lubeluzole intravenous solutions
AU693354B2 (en) * 1995-04-10 1998-06-25 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
CA2228054A1 (en) * 1995-10-25 1997-05-01 Janssen Pharmaceutica N.V. Lubeluzole n-oxide
US6025355A (en) 1997-05-19 2000-02-15 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
CA2258165C (en) * 1996-06-27 2009-03-03 Marc Gaston Venet N-[4-(heteroarylmethyl)phenyl]-heteroarylamines
US6242198B1 (en) 1996-07-25 2001-06-05 Cambridge Neuroscience, Inc. Methods of treatment of eye trauma and disorders
US6756389B2 (en) 1996-08-09 2004-06-29 Cambridge Neuroscience, Inc. Pharmaceutically active compounds and methods of use
BR9814956A (pt) * 1997-11-10 2000-10-03 Bristol Myers Squibb Co Inibidores de benzotiazol da tirosina cinase de proteìna
GB9815785D0 (en) * 1998-07-20 1998-09-16 Cerebrus Ltd Chemical compounds
AU4537500A (en) 1999-05-12 2000-12-05 Neurosearch A/S Ion channel modulating agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963732A (en) * 1973-05-30 1976-06-15 Tiberio Bruzzese Process for preparing dihydroxydiphenylmethane derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
US4310658A (en) * 1980-06-18 1982-01-12 Allied Corporation Production of polyester thermally stabilized with an oxirane
CA1260474A (en) * 1984-12-03 1989-09-26 Raymond A. Stokbroekx Benzoxazol- and benzothiazolamine derivatives
US4861785A (en) * 1984-12-03 1989-08-29 Janssen Pharmaceutica N.V. Benzoxazol-and benzothiazolamine derivatives, useful as anti-anoxic agents
KR930005004B1 (ko) * 1985-04-15 1993-06-11 쟈안센 파아마슈우티카 엔. 부이. 치환된 n-[(4-피페리디닐)알킬]이환 축합 옥사졸아민 및 티아졸아민의 제조방법
US4749702A (en) * 1985-04-15 1988-06-07 Janssen Pharmaceutica N. V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4689330A (en) * 1985-04-15 1987-08-25 Janssen Pharmaceutica N.V. Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
US4717760A (en) * 1986-07-10 1988-01-05 The Dow Chemical Company Fluorinated tris-epoxides based on triphenyl methane
JPH0643426B2 (ja) * 1986-07-25 1994-06-08 東京田辺製薬株式会社 イミダゾ〔４，５−ｂ〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol

Also Published As

Publication number Publication date
FI933719A0 (fi) 1993-08-24
IL100952A (en) 1995-12-31
HK172296A (en) 1996-09-20
GR3018692T3 (en) 1996-04-30
DE69206787T2 (de) 1996-06-05
EP0573473A1 (en) 1993-12-15
KR0165901B1 (en) 1999-01-15
IE69567B1 (en) 1996-10-02
ES2083737T3 (es) 1996-04-16
CS51292A3 (en) 1992-09-16
EP0501552A1 (en) 1992-09-02
ZW1992A1 (en) 1993-09-22
RU2094434C1 (ru) 1997-10-27
AU649788B2 (en) 1994-06-02
CN1064865A (zh) 1992-09-30
CN1033454C (zh) 1996-12-04
JP2825652B2 (ja) 1998-11-18
HU211560A9 (en) 1995-12-28
ATE131478T1 (de) 1995-12-15
US5675027A (en) 1997-10-07
MX9200777A (es) 1992-08-01
TNSN92017A1 (fr) 1993-06-08
IL100952A0 (en) 1992-11-15
LV11689B (en) 1997-08-20
AU1208592A (en) 1992-09-15
HUT67695A (en) 1995-04-28
DE69206787D1 (de) 1996-01-25
FI933719L (fi) 1993-08-24
JPH06505012A (ja) 1994-06-09
CN1113437A (zh) 1995-12-20
US5434168A (en) 1995-07-18
SK278705B6 (sk) 1998-01-14
HU9302395D0 (en) 1993-11-29
LV11689A (lv) 1997-02-20
WO1992014731A1 (en) 1992-09-03
RU2106348C1 (ru) 1998-03-10
MA22447A1 (fr) 1992-10-01
NZ248437A (en) 1994-07-26
EE02983B1 (et) 1997-04-15
NO300591B1 (no) 1997-06-23
CY1924A (en) 1997-03-07
BG62332B1 (bg) 1999-08-31
DZ1560A1 (fr) 2002-02-17
CA2104000A1 (en) 1992-08-26
RU95112519A (ru) 1997-04-20
FI933719A7 (fi) 1993-08-24
NZ241592A (en) 1994-07-26
CZ284705B6 (cs) 1999-02-17
ZA921341B (en) 1993-08-24
RO112959B1 (ro) 1998-02-27
BG98068A (bg) 1994-06-30
IL113837A0 (en) 1995-08-31
NO933010L (no) 1993-08-24
TW218016B (Direct) 1993-12-21
CN1043609C (zh) 1999-06-16
PL168791B1 (pl) 1996-04-30
EP0573473B1 (en) 1995-12-13
DK0573473T3 (da) 1996-01-29
IE920575A1 (en) 1992-08-26
NO933010D0 (no) 1993-08-24
CN1117048A (zh) 1996-02-21

Similar Documents

Publication Publication Date Title
IL113837A (en) [(3,4-difluorophenoxy) methyl] oxirane and its preparation
CN1038936C (zh) 甲酰胺衍生物的制备方法
EP0184257B1 (en) Benzoxazol- and benzothiazolamine derivatives
JP5188501B2 (ja) モンテルカストおよびそのアミン塩類の精製方法
JP2010524907A (ja) トリアゾロピリジンカルボキサミド誘導体、その調製およびその治療的使用
AU737334B2 (en) Halogen substituted tetracyclic tetrahydrofuran derivatives
EP0912533B1 (en) Alkylaminobenzothiazole and -benzoxazole derivatives
CA2295800A1 (en) Resolution of amines
CN1072661C (zh) 新的取代[2－(1－哌嗪基)乙氧基]甲基化合物
WO2010000456A1 (en) Substituted 6- (1-piperazinyl) -pyridazines as 5-ht6 receptor antagonists
IE66198B1 (en) Antipsychotic 3-piperazinylbenzazole derivatives
TWI380975B (zh) 製造胺基酚類化合物的方法
JP7292517B2 (ja) オキセタン－２－イルメタンアミンの調製のためのプロセスおよび中間体
CN87104641A (zh) 4-(芳酰氨基)哌啶丁酰氨衍生物
Adamo et al. An Improved Resolution Of 2-Methyl Piperidine And Its Use in The Synthesis Of Homochiral Trans-2, 6-Dialkyl Piperidines
HK1047275A1 (en) Benzofurane derivatives
CN101048392A (zh) 新用途
US4749702A (en) Antidepressive substituted N-[(4-piperidinyl)alkyl] bicyclic condensed oxazol- and thiazolamines
CN1044707C (zh) 取代的氨烷基氨基吡啶,及制备方法,应用和含有该化合物的药物组合物
CN1557808A (zh) 3－取代哌嗪三氮唑醇类抗真菌化合物及其盐类
US5010198A (en) Intermediates for the synthesis of benzoxazol- and benzothiazolamine derivatives, useful as anti-anoxic agents
US8765979B2 (en) Synthesis of (2S-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3 dioxolane-4-methanol methanesulfonate(ester)
KR20220099201A (ko) 광학분할에 의한 새로운 레보세티리진의 제조방법
CN1678601A (zh) 由粘卤酸制备官能化的γ－丁内酯的方法
CN1856479A (zh) γ－分泌酶抑制剂

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed